Phosphatidyl Serine Complex 500 mg
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 10% of ingredients have research evidence
B
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1 Capsule(s)
Serving Size
Fat/Fatty Acid
Product Type
10%
Evidence Coverage
Supplement Facts — Evidence Check
8 mg
(2% DV)
📊 Market median: 99.0mg (503 products)
📚 12 studies (Tier A: 0, B: 3)
Potassium
3 mg
(1% DV)
Phosphatidyl Serine Complex
500 mg
Alpha-Linolenic Acid
10 mg
Linoleic Acid
85 mg
Oleic Acid
15 mg
Palmitic Acid
27 mg
Stearic Acid
6 mg
Capric Acid
51 mg
Caprylic Acid
120 mg
Other Ingredients
Soybean Oil
Gelatin
Glycerin
Water
Label Claims — Verification
❓
All Other
All Other (98% of products)
Structure/Function (89% of products)
Nutrient (76% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested Use: As a dietary supplement, adults take one (1) capsule, one (1) to three (3) times daily with meals, or as directed by a health care professional.
⚠️ Warnings & Precautions
Keep out of reach of children.
🧪 Formulation Notes
Contains No Added sugar, salt, dairy, yeast, wheat, corn, soy, preservatives, artificial colors or flavors.
Additional Information
"We Make It Better..."
#10120
QUALITY AND POTENCY GUARANTEED
Store in a cool, dry place and away from direct light.
Product Details
DSLD Entry Date
2013-03-25
Product Type
Fat/Fatty Acid
Form
Softgel Capsule
Brand
Martin Avenue Pharmacy
DSLD ID
19479
Data Updated
2026-04-11
Research Evidence
46
Research Sources
55
Avg Quality Score
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
B
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
B
Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
B
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
B
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
B
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Compare Similar Products
Phosphatidyl Serine Complex 500 mg
Viva Vitamins
100
Natural Soya Lecithin 300 mg
Solgar
100
Natural Soya Lecithin 300 mg
Solgar
100
CLA 2000 2000 mg
Zazzee Naturals
100
CLA 3600
Zazzee Naturals
100